Hikma Pharmaceuticals
Pharmaceuticals
HIK.L
GBX 1,738 2
Share price
$ 4.9 bn
Market Cap
$ 5.5 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Hikma Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 124 Kt (-0.44 /-0.4% y-o-y). Also positively, carbon intensity decreased to 53 t (-3.5 /-6.2% y-o-y).
Hikma Pharmaceuticals reported Scope 3 emissions for the the twelve months ending31 December 2020 at 0.8
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.
Copyright © 2022 Exerica. All rights reserved.